Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The L2 protein is the minor capsid protein of Human papillomavirus type 16 (HPV16), a high-risk HPV genotype associated with several human cancers, including cervical cancer. L2 plays multiple critical roles in both virus assembly and infection, including capsid assembly, infectious entry, and nuclear import of viral DNA. It is a target for broad-spectrum vaccine development due to its cross-neutralizing epitopes.
Neutralization of viral infectivity (through antibody binding)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 16 L2 Protein (HPV16 L2).